Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Synthetic antibody mimetic compounds (SYAMS) targeting cancer, especially prostate cancer

Synthetic antibody mimetic compounds (SYAMS) targeting cancer, especially prostate cancer

US Patent 12042542 · Granted Jul 23, 2024

Estimated economic value: $435,088,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Bifunctional small molecules to target the selective degradation of circulating 2025
Bifunctional small molecules to target the selective degradation of circulating 2025
Reprogramming urokinase into an antibody-recruiting anticancer agent2025
Molecular degraders of extracellular proteins2025
Therapeutic DNP derivatives and methods using same2024
CD16a binding agents and uses thereof2024
Molecular degraders of extracellular proteins2024
Bi-functional molecules to degrade circulating proteins2024
Chimeric small molecules for the recruitment of antibodies to cancer cells2024
Decarboxylated cannabis compositions and methods of making the same2024
Reprogramming urokinase into an antibody-recruiting anticancer agent2024
Bifunctional molecules with antibody-recruiting and entry inhibitory activity ag2024